I interviewed a City fund manager the other day who is so bearish about the prospects for the world pharmaceutical industry that he won't give house room in his portfolio to a single drug company share.The gloomy prognosis for the likes of GlaxoSmithKline and AstraZeneca
The pharmaceutical business was once run by men and women in white coats. Heroic figures, they peered into test tubes and Petri dishes, made startling discoveries, produced the necessary pills and saved lives. Or so it seemed, anyway.
When it comes to RFID, the pharmaceutical industry is as different from other markets as a pill is from an M&M. Drug manufacturers are as interested in radio frequency identification as makers of Executive Editor consumer packaged goods. But the needs and goals